GSK Plans Recall After FDA Warning Over Tainted Batches
GlaxoSmithKline PLC on Tuesday said it plans a recall involving antidepressant Paxil after being slapped with a U.S. Food and Drug Administration warning letter over shipment of potentially contaminated active ingredients...To view the full article, register now.
Already a subscriber? Click here to view full article